1.
Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
by Wissemann, William T
American journal of human genetics, 2013-11-07, Vol.93 (5), p.984-993
2.
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis
by Factor, Stewart A
Journal of neurology, neurosurgery and psychiatry, 2011-05, Vol.82 (5), p.564-568
3.
LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago
by Zabetian, Cyrus P
American journal of human genetics, 2006, Vol.79 (4), p.752-758
4.
Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history
by ROSEN, Ami R
Neurogenetics, 2007, Vol.8 (4), p.263-270
5.
Parkinson's disease: the treatment of drug-induced hallucinations and psychosis
by Molho, E S
Current neurology and neuroscience reports, 2001-07, Vol.1 (4), p.320-328
6.
Psychogenic movement disorders: frequency, clinical profile, and characteristics
by Factor, S A
Journal of neurology, neurosurgery and psychiatry, 1995-10, Vol.59 (4), p.406-412
7.
Emergency department presentations of patients with Parkinson's disease
by Factor, Stewart A
The American journal of emergency medicine, 2000, Vol.18 (2), p.209-215
8.
Cognitive domains that predict time to diagnosis in prodromal Huntington disease
by Harrington, Deborah Lynn
Journal of neurology, neurosurgery and psychiatry, 2012-06, Vol.83 (6), p.612-619
9.
DIAGNOSTIC CONSIDERATIONS IN EVALUATING GERIATRIC PATIENTS WITH MOVEMENT DISORDERS: Session 105
by Mack, Joel
The American journal of geriatric psychiatry, 2019-03, Vol.27 (3), p.S6-S7
10.
DIAGNOSTIC CONSIDERATIONS IN EVALUATING GERIATRIC PATIENTS WITH MOVEMENT DISORDERS
by Mack, Joel
The American journal of geriatric psychiatry, 2019-03, Vol.27 (3), p.S6-S7
11.
Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiologi...
by Calle, EE
The Lancet (British edition), 1996, Vol.347 (9017), p.1713
12.
Genome Screen to Identify Susceptibility Genes for Parkinson Disease in a Sample without parkin Mutations
by Pankratz, Nathan
American journal of human genetics, 2002, Vol.71 (1), p.124-135
13.
Significant Linkage of Parkinson Disease to Chromosome 2q36-37
by Pankratz, Nathan
American journal of human genetics, 2003-04, Vol.72 (4), p.1053-1057
14.
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of ‘off’ episodes in patients with Parkinson's disease...
by Lew, Mark F
Current medical research and opinion, 2007-04, Vol.23 (4), p.741-750
